Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Excision of Lymph Node Trial (EXCILYNT) (Mel69)
Recruiting · NCT05839912 · Registry updated 2025-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Excision of Lymph Node Trial (EXCILYNT) (Mel69) | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not applicable | 2025-09-17 | NCT05839912 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Craig L Slingluff, Jr | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Cancer Center at the University of Virginia | Charlottesville | United States | 1 |
| Duke University Health System | Durham | United States | 31 |
| Emory University | Atlanta | United States | 262 |
| Memorial Sloan Kettering Cancer Center | New York | United States | 1000 |
| University of Maryland | Baltimore | United States | 86 |
| University of Michigan | Ann Arbor | United States | 538 |
| University of Pennsylvania | Philadelphia | United States | 507 |